A new trading day began on Tuesday, with Terns Pharmaceuticals Inc (NASDAQ: TERN) stock price up 5.78% from the previous day of trading, before settling in for the closing price of $2.94. TERN’s price has ranged from $1.87 to $11.40 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -20.00% over the past five years. Meanwhile, its annual earnings per share averaged -10.44%. With a float of $65.30 million, this company’s outstanding shares have now reached $87.13 million.
Let’s look at the performance matrix of the company that is accounted for 59 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Terns Pharmaceuticals Inc (TERN) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Terns Pharmaceuticals Inc is 25.20%, while institutional ownership is 79.10%. The most recent insider transaction that took place on Apr 01 ’25, was worth 2,366. In this transaction Chief Medical Officer of this company sold 952 shares at a rate of $2.49, taking the stock ownership to the 53,317 shares. Before that another transaction happened on Nov 30 ’24, when Company’s Chief Business Officer bought 2,250 for $5.11, making the entire transaction worth $11,498. This insider now owns 2,250 shares in total.
Terns Pharmaceuticals Inc (TERN) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -10.44% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -12.26% during the next five years compared to 16.38% growth over the previous five years of trading.
Terns Pharmaceuticals Inc (NASDAQ: TERN) Trading Performance Indicators
Here are Terns Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 23.14.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.13, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach -1.38 in one year’s time.
Technical Analysis of Terns Pharmaceuticals Inc (TERN)
Terns Pharmaceuticals Inc (NASDAQ: TERN) saw its 5-day average volume 0.89 million, a negative change from its year-to-date volume of 1.37 million. As of the previous 9 days, the stock’s Stochastic %D was 83.64%. Additionally, its Average True Range was 0.26.
During the past 100 days, Terns Pharmaceuticals Inc’s (TERN) raw stochastic average was set at 22.25%, which indicates a significant decrease from 90.35% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 90.88% in the past 14 days, which was higher than the 78.14% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.09, while its 200-day Moving Average is $5.98. Nevertheless, the first resistance level for the watch stands at $3.28 in the near term. At $3.45, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.66. If the price goes on to break the first support level at $2.90, it is likely to go to the next support level at $2.69. The third support level lies at $2.52 if the price breaches the second support level.
Terns Pharmaceuticals Inc (NASDAQ: TERN) Key Stats
With a market capitalization of 271.50 million, the company has a total of 87,298K Shares Outstanding. Currently, annual sales are 0 K while annual income is -88,850 K. The company’s previous quarter sales were 0 K while its latest quarter income was -21,800 K.
